Quintiles

Quintiles, Quest Diagnostics launch Q2 Solutions

Monday, July 6, 2015 09:56 AM

Quintiles and Quest Diagnostics have launched Q2 Solutions, a new combined clinical trials laboratory services organization. Q2 Solutions brings together the clinical trials laboratory operations of the two parent organizations to provide biopharmaceutical customers with the diverse capabilities and end-to-end services required in the rapidly evolving biopharmaceutical industry. The launch of Q2Solutions is the result of the close of the previously announced global clinical trials laboratory services joint-venture transaction.

More... »


Quintiles launches new predictive and advanced analytics capabilities

Friday, June 19, 2015 12:00 PM

Global CRO Quintiles has added advanced statistical monitoring and predictive analytics capabilities to its risk-based monitoring (RBM) solution. Predictive and Advanced Analytics combine Quintiles' experience in RBM with its therapeutic and statistical sciences heritage to enable study teams to identify the right signals and predict clinical trial site performance and potential patient safety issues.

More... »


Quintiles launches Infosario One mobile app

Wednesday, June 17, 2015 08:46 AM

Global CRO Quintiles is extending its Quintiles Infosario technology platform with mobile access to critical clinical trial information. Using the mobile app, key stakeholders in the drug development process can conveniently access site start-up, recruitment and compliance information as well as status updates on data queries and project milestones.

More... »

Society for Clinical Research Sites launches program for Asia-Pac Site Solutions Summit

Wednesday, June 17, 2015 08:30 AM

The Society for Clinical Research Sites (SCRS), a global trade organization fully dedicated to representing the interests of clinical research sites, has announced a program for the 2015 Asia-Pac Site Solutions Summit. The Asia-Pac Site Solutions Summit will be July 30-31, 2015 in Melbourne, Australia. The Summit is open to clinical research investigators, site executives and industry stakeholders.

More... »

New Synexus board gears up for expansion through organic growth and acquisition

Wednesday, June 10, 2015 11:07 AM

Following the completion of the management buyout of Synexus, the new board confirms its intention to expand the footprint of the company through organic growth and acquisition. Synexus, a multi-national company dedicated to the recruitment and running of clinical trials at its own research centers across the globe, intends to become a major player in the U.S., continue to expand its existing network of sites in Europe and Africa and develop a presence in Asia and South America.

More... »

Cenduit to hire globally

Friday, May 29, 2015 02:38 PM

Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, has hired 43 new professionals so far in 2015 and is actively looking to fill a number of new positions in the U.S. and abroad.

More... »

Quintiles opens Greater China regional headquarters in Shanghai

Friday, May 29, 2015 02:36 PM

Quintiles has opened the Quintiles Greater China Regional Headquarters 17 years after Quintiles first opened an office in Shanghai with 20 employees across Greater China. Quintiles’ 43,000 square feet headquarters in Shanghai’s Feng Lin Science Park now has almost 300 employees and is designed to host 450.

More... »

Quintiles launches new solution for emerging Asia-Pacific biopharmaceutical companies

Thursday, May 28, 2015 03:06 PM

Global CRO Quintiles has launched a new solution set tailored to meet the needs of emerging biopharmaceutical companies in the Asia-Pacific healthcare market.

More... »

Quintiles VP Dr. Judith Beach joins ACRES board of directors

Monday, May 18, 2015 02:23 PM

The Alliance for Clinical Research Excellence and Safety (ACRES) has added Dr. Judith Beach, senior vice president and senior associate general counsel for regulatory affairs at Quintiles, to its board of directors. Beach brings her wide-ranging experience in legal and regulatory counsel on international and domestic regulatory issues in the pharmaceutical, medical device and biotechnology industries, as well as her chief privacy officer responsibilities, to ACRES mission of building a global system for accountable clinical research.

More... »

Moderna launches venture company Elpidera for rare diseases

Wednesday, May 13, 2015 11:57 AM

Moderna Therapeutics, a Cambridge, Mass.-based developer of messenger RNA (mRNA) Therapeutics, has launched Elpidera, a new Moderna venture focused exclusively on the advancement of mRNA-based medicines for the treatment of rare diseases.

More... »


CWWeekly

July 6

FDA sued by advocacy groups seeking hepatitis C trials data

Google to test health-tracking wristband to collect clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs